Updating results

2866 results

Sort: Relevance | Date

Bair Hugger for measuring core temperature during perioperative care (MIB99)

Advice on the use of the Bair Hugger system for measuring core temperature during perioperative care to aid local decision-making

Medtech innovation briefing Published March 2017

Cellvizio confocal endomicroscopy system for characterising pancreatic cysts (MIB69)

Advice on the use of Cellvizio confocal endomicroscopy system (CLS) for characterising pancreatic cysts to aid local decision-making

Medtech innovation briefing Published June 2016

QTUG for assessing falls risk and frailty (MIB73)

Advice on the use of the Quantitative Timed Up and Go (QTUG) to assess mobility, falls risk and frailty during the standard Timed Up and Go (TUG) test to aid…

Medtech innovation briefing Published July 2016

Stretta System for gastro-oesophageal reflux disease (MIB74)

Advice on the use of Stretta System for gastro-oesophageal reflux disease (GORD)

Medtech innovation briefing Published July 2016

Axxent electronic brachytherapy system for early stage breast cancer (MIB76)

Advice on the use of the Axxent electronic brachytherapy system for treating early stage breast cancer to aid local decision-making

Medtech innovation briefing Published August 2016

CORTRAK 2 Enteral Access System for placing nasoenteral feeding tubes (MIB48)

Advice on the use of the CORTRAK 2 Enteral Access System (EAS) for the placement of nasoenteral feeding tube to aid local decision-making

Medtech innovation briefing Published January 2016 Last updated December 2016

EarlySense for heart and respiratory monitoring and predicting patient deterioration (MIB49)

Advice on the use of EarlySense for heart and respiratory monitoring and predicting patient deterioration to aid local decision-making

Medtech innovation briefing Published January 2016

Acoustic CR Neuromodulation for adults with chronic subjective tonal tinnitus (MIB5)

Advice on the use of the Acoustic CR Neuromodulation system for adults with chronic subjective tonal tinnitus to aid local decision-making

Medtech innovation briefing Published June 2014

BladderScan BVI 9400 3D portable ultrasound scanner for measuring bladder volume (MIB50)

Advice on the BladderScan BVI 9400 3D portable ultrasound scanner for measuring bladder volume to aid local decision-making

Medtech innovation briefing Published January 2016

MiniMed 640G system with SmartGuard for managing blood glucose levels in people with type 1 diabetes (MIB51)

Advice on the MiniMed 640G system with SmartGuard for managing blood glucose levels in type 1 diabetes to aid local decision-making

Medtech innovation briefing Published February 2016

Xpert Carba-R to identify people carrying carbapenemase-producing organisms (MIB52)

Advice on the Xpert Carba-R test for identifying organisms that have carbapenemase genes to aid local decision-making

Medtech innovation briefing Published February 2016

Aquilion PRIME CT scanner for imaging coronary artery disease in adults in whom imaging is difficult (MIB53)

Advice on the use of the Aquilion PRIME CT scanner for imaging coronary artery disease to aid local decision-making

Medtech innovation briefing Published March 2016 Last updated July 2017

PneuX for preventing ventilator-associated pneumonia in intensive care (MIB45)

Advice on the use of PneuX for preventing ventilator-associated pneumonia in intensive care to aid local decision-making

Medtech innovation briefing Published November 2015

AdenoPlus point-of-care test for diagnosing adenoviral conjunctivitis (MIB46)

Advice on the use of the AdenoPlus point-of-care test for diagnosing adenoviral conjunctivitis to aid local decision-making

Medtech innovation briefing Published December 2015

TearLab osmolarity system for diagnosing dry eye disease (MIB47)

Advice on the use of the TearLab osmolarity system for diagnosing dry eye disease to aid local decision-making

Medtech innovation briefing Published December 2015

TheraSphere for treating operable and inoperable hepatocellular carcinoma (MIB62)

Advice on the use of TheraSphere for treating operable and inoperable hepatocellular carcinoma (liver cancer) to aid local decision-making

Medtech innovation briefing Published March 2016

SIR-Spheres for treating inoperable hepatocellular carcinoma (MIB63)

Advice on the use of SIR-Spheres for treating inoperable hepatocellular carcinoma (HCC) (liver cancer) to aid local decision-making

Medtech innovation briefing Published March 2016

CareLink network service for remote monitoring of people with cardiac devices (MIB64)

Advice on the use of the CareLink network service for monitoring cardiac devices to aid local decision-making

Medtech innovation briefing Published May 2016

Prolaris gene expression assay for assessing long-term risk of prostate cancer progression (MIB65)

Advice on the use of the Prolaris gene expression assay for assessing the risk of prostate cancer progression to aid local decision-making

Medtech innovation briefing Published May 2016

Active B12 assay for diagnosing vitamin B12 deficiency (MIB40)

Advice on the use of the Active B12 assay for diagnosing vitamin B12 deficiency to aid local decision-making

Medtech innovation briefing Published September 2015

PROPATEN heparin-bonded vascular graft for peripheral arterial disease (MIB42)

Advice on the use of the PROPATEN heparin-bonded vascular graft for treating peripheral arterial disease to aid local decision-making

Medtech innovation briefing Published October 2015

ATEC system for vacuum-assisted breast biopsy (MIB43)

Advice on the use of the ATEC system for vacuum-assisted breast biopsy to aid local decision-making

Medtech innovation briefing Published November 2015

Icare rebound tonometer to measure intraocular pressure (MIB57)

Advice on the use of the Icare rebound tonometer to measure intraocular pressure and assess the risk of developing glaucoma to aid local decision-making

Medtech innovation briefing Published March 2016

Mersey Burns for calculating fluid resuscitation volume when managing burns (MIB58)

Advice on the use of the Mersey Burns app for calculating fluid resuscitation when managing burns to aid local decision-making

Medtech innovation briefing Published March 2016

Otovent nasal balloon for otitis media with effusion (MIB59)

Advice on the use of the Otovent nasal balloon for relieving the symptoms of otitis effusion (glue ear) to aid local decision-making

Medtech innovation briefing Published March 2016

ClearWay RX for drug delivery to coronary artery thrombotic lesions (MIB55)

Advice ClearWay RX for drug delivery to coronary artery thrombotic lesions to aid local decision-making

Medtech innovation briefing Published March 2016

ODFS Pace and Pace XL functional electrical stimulation devices for treating drop foot (MIB56)

Advice on the use of ODFS Pace and Pace XL functional electrical stimulation devices for treating drop foot to aid local decision-making

Medtech innovation briefing Published March 2016

AccuVein AV400 for vein visualisation (MIB6)

Advice on the use of AccuVein AV400 for vein visualisation (peripheral venous access) to aid local decision-making

Medtech innovation briefing Published June 2014

TactiCath Quartz catheter for percutaneous radiofrequency ablation in atrial fibrillation (MIB60)

Advice on the use of the TactiCath Quartz catheter for percutaneous radiofrequency ablation in atrial fibrillation to aid local decision-making

Medtech innovation briefing Published March 2016

ThermoCool SmartTouch catheter for percutaneous radiofrequency ablation in atrial fibrillation (MIB61)

Advice on the use of the ThermoCool SmartTouch catheter for percutaneous radiofrequency ablation in atrial fibrillation to aid local decision-making

Medtech innovation briefing Published March 2016

Somatom Definition Edge CT scanner for imaging coronary artery disease in adults in whom imaging is difficult (MIB54)

Advice on the use of the Somatom Definition Edge CT scanner for imaging coronary artery disease to aid local decision-making

Medtech innovation briefing Published March 2016 Last updated July 2017

Obese, overweight with risk factors: liraglutide (Saxenda) (ES14)

Summary of the evidence on liraglutide for managing obesity and overweight with risk factors in adults to inform local NHS planning and decision-making

Evidence summary Published June 2017

Early breast cancer (preventing recurrence and improving survival): adjuvant bisphosphonates (ES15)

Summary of the evidence on adjuvant bisphosphonates for preventing recurrence or improving survival in people with early breast cancer

Evidence summary Published July 2017

Antimicrobial prescribing: Ceftazidime/avibactam (ES16)

Summary of the evidence on ceftazidime/avibactam for complicated intra-abdominal and UTI infections and hospital-acquired pneumonia

Evidence summary: antimicrobial prescribing Published November 2017

Hyperhidrosis: oxybutynin (ES10)

Summary of the evidence on oxybutynin for treating hyperhidrosis (excessive sweating) to inform local NHS planning and decision-making

Evidence summary Published March 2017

Minimal change disease and focal segmental glomerulosclerosis in adults: rituximab (ES1)

Summary of the evidence on rituximab for minimal change disease and focal segmental glomerulosclerosis to inform local NHS planning and decision-making

Evidence summary Published November 2016

Mitochondrial disorders in children: Co-enzyme Q10 (ES11)

Summary of the evidence on co-enzyme Q10 for mitochondrial disorders in children to inform local NHS planning and decision-making

Evidence summary Published March 2017

Preventing recurrence of Clostridium difficile infection: bezlotoxumab (ES13)

Summary of the evidence on bezlotoxumab for preventing the recurrence of Clostridium difficile (C difficile) infection

Evidence summary Published June 2017

Non-cystic fibrosis bronchiectasis: inhaled tobramycin (ES12)

ES12 Key points The content of this evidence summary

Evidence summary Published April 2017

Coronary revascularisation: Cangrelor (ESNM63)

Summary of the evidence on cangrelor for coronary revascularisation to inform local NHS planning and decision-making

Evidence summary Published November 2015

Diabetes mellitus type 1 and type 2: insulin glargine biosimilar (Abasaglar) (ESNM64)

Summary of the evidence on insulin glargine biosimilar (Abasaglar) for type 1 and type 2 diabetes mellitus to inform local NHS planning and decision-making

Evidence summary Published December 2015

Type 2 diabetes mellitus in adults: high-strength insulin glargine 300 units/ml (Toujeo) (ESNM65)

Summary of the evidence on high-strength insulin glargine 300 units/ml (Toujeo) for type 2 diabetes mellitus to inform local NHS planning and decision-making

Evidence summary Published December 2015

External genital and perianal warts: green tea (Camellia sinensis) leaf extract 10% ointment (ESNM66)

Summary of the evidence on green tea (Camellia sinensis) leaf extract 10% ointment for treating external genital and perianal warts to inform local NHS planning

Evidence summary Published December 2015

Restless legs syndrome: Oxycodone/naloxone prolonged release (ESNM67)

Summary of the evidence on oxycodone/naloxone prolonged release for treating restless leg syndrome (RLS) to inform local NHS planning and decision-making

Evidence summary Published December 2015

Type 2 diabetes: insulin degludec/liraglutide (Xultophy) (ESNM60)

Summary of the evidence on insulin degludec/liraglutide (Xultophy) for treating type 2 diabetes to inform local NHS planning and decision-making

Evidence summary Published July 2015

Orthostatic hypotension due to autonomic dysfunction: midodrine (ESNM61)

Summary of the evidence on midodrine for orthostatic hypotension due to autonomic dysfunction to inform local NHS planning and decision-making

Evidence summary Published October 2015

Type 1 diabetes mellitus in adults: high-strength insulin glargine 300 units/ml (Toujeo) (ESNM62)

Summary of the evidence on high-strength insulin glargine 300 units/ml (Toujeo) for type 1 diabetes mellitus to inform local NHS planning and decision-making

Evidence summary Published October 2015

Chronic obstructive pulmonary disease: aclidinium/formoterol (ESNM57)

Summary of the evidence on aclidinium/formoterol for chronic obstructive pulmonary disease (COPD) to inform local NHS planning and decision-making

Evidence summary Published April 2015

Ulcerative colitis: budesonide multimatrix (Cortiment) (ESNM58)

Summary of the evidence on budesonide multimatrix (Cortiment) for treating ulcerative colitis (UC) to inform local NHS planning and decision-making

Evidence summary Published June 2015

Type 2 diabetes: dulaglutide (ESNM59)

Summary of the evidence on dulaglutide for treating type 2 diabetes to inform local NHS planning and decision-making

Evidence summary Published June 2015